Free fatty acid availability is closely related to myocardial lipid storage and cardiac function in hypoglycemia counterregulation

American Journal of Physiology - Endocrinology and Metabolism

Volumn 308, Issue 8, 2015, Pages E631-E640

  Winhofer, Yvonne ^a   Krššák, Martin ^a   Wolf, Peter ^a   Anderwald, Christian Heinz ^a,b,c   Geroldinger, Angelika ^a   Heinze, Georg ^a   Baumgartner Parzer, Sabina ^a   Marculescu, Rodrig ^a   Stulnig, Thomas ^a   Wolzt, Michael ^a   Trattnig, Siegfried ^a   Luger, Anton ^a   Krebs, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Mariahilf Community Pharmacy   (Austria)

^c Specialized Hospital Complex Agathenhof   (Austria)

Author keywords

Acipimox; Cardiac function; Cardiac magnetic resonance imaging and spectroscopy; Catecholamine mediated lipolysis; Free fatty acids; Hypoglycemia; Insulin hypoglycemia test; Myocardial lipid content

Indexed keywords

FATTY ACID; TRIACYLGLYCEROL; ADENYLATE CYCLASE; ADRENALIN; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; INSULIN; NORADRENALIN;

ADIPOSE TISSUE; ADULT; ARTICLE; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN EXPERIMENT; HYPOGLYCEMIA; LIPID COMPOSITION; LIPID STORAGE; LIPOLYSIS; MALE; MYOCARDIAL LIPID CONTENT; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; ALLOSTASIS; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; ETIOLOGY; HEART STROKE VOLUME; HEART VENTRICLE; LIPID METABOLISM; LIVER; METABOLISM; PATHOPHYSIOLOGY; PREVENTION AND CONTROL; WHITE ADIPOSE TISSUE; YOUNG ADULT;

ADENYLATE CYCLASE; ADIPOSE TISSUE, WHITE; ADULT; ALLOSTASIS; EPINEPHRINE; FATTY ACIDS, NONESTERIFIED; HEART VENTRICLES; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSULIN; LIPID METABOLISM; LIPOLYSIS; LIVER; MALE; MODELS, BIOLOGICAL; NOREPINEPHRINE; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 84929624291     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00371.2014     Document Type: Article

References (38)

1. Baer FM, Theissen P, Schneider CA, Voth E, Schicha H, Sechtem U. [Magnetic resonance tomography imaging techniques for diagnosing myocardial vitality]. Herz 19: 51–64, 1994.
2. Barkhausen J, Ruehm SG, Goyen M, Buck T, Laub G, Debatin JF. MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology 219: 264–269, 2001.
3. Bland JM, Altman DG. Calculating correlation coefficients with repeated observations: Part 1—Correlation within subjects. BMJ 310: 446, 1995.
4. Djousse L, Benkeser D, Arnold A, Kizer JR, Zieman SJ, Lemaitre RN, Tracy RP, Gottdiener JS, Mozaffarian D, Siscovick DS, Mukamal KJ, Ix JH. Plasma free fatty acids and risk of heart failure: the Cardiovascular Health Study. Circ Heart Fail 6: 964–969, 2013.
5. Erturk E, Jaffe CA, Barkan AL. Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test. J Clin Endocrinol Metab 83: 2350–2354, 1998.
6. Finucane FM, Liew A, Thornton E, Rogers B, Tormey W, Agha A. Clinical insights into the safety and utility of the insulin tolerance test (ITT) in the assessment of the hypothalamo-pituitary-adrenal axis. Clin Endocrinol 69: 603–607, 2008.
7. Fisher BM, Gillen G, Dargie HJ, Inglis GC, Frier BM. The effects of insulin-induced hypoglycaemia on cardiovascular function in normal man: studies using radionuclide ventriculography. Diabetologia 30: 841–845, 1987.
8. Fisher BM, Gillen G, Hepburn DA, Dargie HJ, Frier BM. Cardiac responses to acute insulin-induced hypoglycemia in humans. Am J Physiol Heart Circ Physiol 258: H1775–H1779, 1990.
9. Florian JP, Pawelczyk JA. Non-esterified fatty acids increase arterial pressure via central sympathetic activation in humans. Clin Sci 118: 61–69, 2010.
10. Halbirk M, Nørrelund H, Møller N, Schmitz O, Gøtzsche L, Nielsen R, Nielsen-Kudsk JE, Nielsen SS, Nielsen TT, Eiskjær H, Bøtker HE, Wiggers H. Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function. Am J Physiol Heart Circ Physiol 299: H1220–H1225, 2010.
11. Hammer S, van der Meer RW, Lamb HJ, de Boer HH, Bax JJ, de Roos A, Romijn JA, Smit JW. Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 295: E714–E718, 2008.
12. Hammer S, van der Meer RW, Lamb HJ, Schar M, de Roos A, Smit JW, Romijn JA. Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men. J Clin Endocrinol Metab 93: 497–503, 2008.
13. Jankovic D, Winhofer Y, Promintzer-Schifferl M, Wohlschlager- Krenn E, Anderwald CH, Wolf P, Scherer T, Reiter G, Trattnig S, Luger A, Krebs M, Krssak M. Effects of insulin therapy on myocardial lipid content and cardiac geometry in patients with type-2 diabetes mellitus. PLoS One 7: e50077, 2012.
14. Knuuti MJ, Maki M, Yki-Jarvinen H, Voipio-Pulkki LM, Harkonen R, Haaparanta M, Nuutila P. The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol 27: 1359–1367, 1995.
15. Korvald C, Elvenes OP, Myrmel T. Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol 278: H1345–H1351, 2000.
16. Krssak M, Hofer H, Wrba F, Meyerspeer M, Brehm A, Lohninger A, Steindl-Munda P, Moser E, Ferenci P, Roden M. Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy. Eur J Radiol 74: e60–e66, 2010.
17. Krssak M, Winhofer Y, Gobl C, Bischof M, Reiter G, Kautzky-Willer A, Luger A, Krebs M, Anderwald C. Insulin resistance is not associated with myocardial steatosis in women. Diabetologia 54: 1871–1878, 2011.
18. Lehto HR, Parkka J, Borra R, Tuunanen H, Lepomaki V, Parkkola R, Knuuti J, Nuutila P, Iozzo P. Effects of acute and one-week fatty acid lowering on cardiac function and insulin sensitivity in relation with myocardial and muscle fat and adiponectin levels. J Clin Endocrinol Metab 97: 3277–3284, 2012.
19. Lucidi P, Rossetti P, Porcellati F, Pampanelli S, Candeloro P, Andreoli AM, Perriello G, Bolli GB, Fanelli CG. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis. Diabetes 59: 1349–1357, 2010.
20. Mohiaddin RH, Amanuma M, Kilner PJ, Pennell DJ, Manzara C, Longmore DB. MR phase-shift velocity mapping of mitral and pulmonary venous flow. J Comput Assist Tomogr 15: 237–243, 1991.
21. Nuutila P, Knuuti MJ, Raitakari M, Ruotsalainen U, Teräs M, Voipio-Pulkki LM, Haaparanta M, Solin O, Wegelius U, Yki-Järvinen H. Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans. Am J Physiol Endocrinol Metab 267: E941–E946, 1994.
22. Paolisso G, Manzella D, Rizzo MR, Ragno E, Barbieri M, Varricchio G, Varricchio M. Elevated plasma fatty acid concentrations stimulate the cardiac autonomic nervous system in healthy subjects. Am J Clin Nutr 72: 723–730, 2000.
23. Pilz S, Scharnagl H, Tiran B, Seelhorst U, Wellnitz B, Boehm BO, Schaefer JR, Marz W. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J Clin Endocrinol Metab 91: 2542–2547, 2006.
24. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785–789, 1963.
25. Reno CM, Daphna-Iken D, Chen YS, VanderWeele J, Jethi K, Fisher SJ. Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation. Diabetes 62: 3570–3581, 2013.
26. Russell RR 3rd, Chyun D, Song S, Sherwin RS, Tamborlane WV, Lee FA, Pfeifer MA, Rife F, Wackers FJ, Young LH. Cardiac responses to insulin-induced hypoglycemia in nondiabetic and intensively treated type 1 diabetic patients. Am J Physiol Endocrinol Metab 281: E1029–E1036, 2001.
27. Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 14: 281–287, 2003.
28. Stirling C, McAleer M, Reckless JP, Campbell RR, Mundy D, Betteridge DJ, Foster K. Effects of acipimox, a nicotinic acid derivative, on lipolysis in human adipose tissue and on cholesterol synthesis in human jejunal mucosa. Clin Sci 68: 83–88, 1985.
29. Szczepaniak LS, Victor RG, Orci L, Unger RH. Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res 101: 759–767, 2007.
30. Taegtmeyer H, Golfman L, Sharma S, Razeghi P, van Arsdall M. Linking gene expression to function: metabolic flexibility in the normal and diseased heart. Ann NY Acad Sci 1015: 202–213, 2004.
31. Trent CM, Yu S, Hu Y, Skoller N, Huggins LA, Homma S, Goldberg IJ. Lipoprotein lipase activity is required for cardiac lipid droplet production. J Lipid Res 55: 645–658, 2014.
32. Tuunanen H, Engblom E, Naum A, Nagren K, Hesse B, Airaksinen KE, Nuutila P, Iozzo P, Ukkonen H, Opie LH, Knuuti J. Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation 114: 2130–2137, 2006.
33. van der Meer RW, Diamant M, Westenberg JJ, Doornbos J, Bax JJ, de Roos A, Lamb HJ. Magnetic resonance assessment of aortic pulse wave velocity, aortic distensibility, and cardiac function in uncomplicated type 2 diabetes mellitus. J Cardiovasc Magn Reson 9: 645–651, 2007.
34. van der Meer RW, Hammer S, Smit JW, Frolich M, Bax JJ, Diamant M, Rijzewijk LJ, de Roos A, Romijn JA, Lamb HJ. Short-term caloric restriction induces accumulation of myocardial triglycerides and decreases left ventricular diastolic function in healthy subjects. Diabetes 56: 2849–2853, 2007.
35. Vila G, Krebs M, Riedl M, Baumgartner-Parzer SM, Clodi M, Maier C, Pacini G, Luger A. Acute effects of hydrocortisone on the metabolic response to a glucose load: increase in the first-phase insulin secretion. Eur J Endocrinol 163: 225–231, 2010.
36. Winhofer Y, Krssak M, Jankovic D, Anderwald CH, Reiter G, Hofer A, Trattnig S, Luger A, Krebs M. Short-term hyperinsulinemia and hyperglycemia increase myocardial lipid content in normal subjects. Diabetes 61: 1210–1216, 2012.
37. Wright RJ, Newby DE, Stirling D, Ludlam CA, Macdonald IA, Frier BM. Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes. Diabetes Care 33: 1591–1597, 2010.
38. Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, Grobbee DE, Kengne AP, Marre M, Heller S, Group AC. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 363: 1410–1418, 2010.